Bifogade filer
PDF
Kurs
-1,13%
Kurs
-1,13%
Open
3,54
High
3,62
Low
3,50
Close
3,50
Kursutveckling under dagen för detta pressmeddelande
(SEK).
Likviditet
0,05 MSEK
Likviditet
0,05 MSEK
Rel. mcap
0,01%
Antal aktier
13 287
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2025-11-20 | N/A | Årsstämma |
| 2025-11-14 | 09:00 | Kvartalsrapport 2026-Q1 |
| 2025-08-28 | 08:30 | Bokslutskommuniké 2025 |
| 2025-05-22 | 09:00 | Kvartalsrapport 2025-Q3 |
| 2025-02-13 | 09:00 | Kvartalsrapport 2025-Q2 |
| 2024-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2024-11-21 | - | Årsstämma |
| 2024-11-15 | - | Kvartalsrapport 2025-Q1 |
| 2024-08-28 | - | Bokslutskommuniké 2024 |
| 2024-05-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-02-22 | - | Kvartalsrapport 2024-Q2 |
| 2023-12-14 | - | Extra Bolagsstämma 2024 |
| 2023-11-24 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2023-11-23 | - | Årsstämma |
| 2023-11-17 | - | Kvartalsrapport 2024-Q1 |
| 2023-08-28 | - | Bokslutskommuniké 2023 |
| 2023-05-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-05-17 | - | Extra Bolagsstämma 2023 |
| 2023-02-23 | - | Kvartalsrapport 2023-Q2 |
| 2022-11-25 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2022-11-24 | - | Årsstämma |
| 2022-11-11 | - | Kvartalsrapport 2023-Q1 |
| 2022-08-26 | - | Bokslutskommuniké 2022 |
| 2022-05-20 | - | Kvartalsrapport 2022-Q3 |
| 2022-02-25 | - | Kvartalsrapport 2022-Q2 |
| 2021-11-26 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2021-11-25 | - | Årsstämma |
| 2021-11-11 | - | Kvartalsrapport 2022-Q1 |
| 2021-08-27 | - | Bokslutskommuniké 2021 |
| 2021-06-17 | - | Extra Bolagsstämma 2022 |
| 2021-05-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-03-02 | - | Extra Bolagsstämma 2021 |
| 2021-02-26 | - | Kvartalsrapport 2021-Q2 |
| 2020-11-27 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2020-11-26 | - | Årsstämma |
| 2020-11-12 | - | Kvartalsrapport 2021-Q1 |
| 2020-08-28 | - | Bokslutskommuniké 2020 |
| 2020-05-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-02-28 | - | Kvartalsrapport 2020-Q2 |
| 2019-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2019-11-21 | - | Årsstämma |
| 2019-11-08 | - | Kvartalsrapport 2020-Q1 |
| 2019-08-30 | - | Bokslutskommuniké 2019 |
| 2019-05-17 | - | Kvartalsrapport 2019-Q3 |
| 2019-02-15 | - | Kvartalsrapport 2019-Q2 |
| 2018-11-16 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2018-11-15 | - | Årsstämma |
| 2018-11-09 | - | Kvartalsrapport 2019-Q1 |
| 2018-08-30 | - | Bokslutskommuniké 2018 |
| 2018-05-18 | - | Kvartalsrapport 2018-Q3 |
| 2018-02-16 | - | Kvartalsrapport 2018-Q2 |
| 2017-11-10 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2017-11-09 | - | Årsstämma |
| 2017-11-02 | - | Kvartalsrapport 2018-Q1 |
| 2017-08-18 | - | Bokslutskommuniké 2017 |
| 2017-05-12 | - | Kvartalsrapport 2017-Q3 |
| 2017-02-10 | - | Kvartalsrapport 2017-Q2 |
| 2017-01-19 | - | Extra Bolagsstämma 2018 |
| 2016-11-18 | - | Kvartalsrapport 2017-Q1 |
| 2016-11-11 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
| 2016-11-10 | - | Årsstämma |
| 2016-08-19 | - | Bokslutskommuniké 2016 |
| 2016-05-13 | - | Kvartalsrapport 2016-Q3 |
| 2016-02-12 | - | Kvartalsrapport 2016-Q2 |
| 2015-11-13 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2024-08-22 10:26:16
Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit our web page to join the digital events: https://hamletbiopharma.com/series-of-digital-events-2024/
- September 18th, 2024, 12:00 CET
- October 23rd, 2024, 12:00 CET
- December 11th, 2024, 12:00 CET
- August 28th, 2024: Year-End Report (Q4) 2023/2024
- October 31st, 2024: Annual Report 2023/2024
- November 15th, 2024: Quarterly Report (Q1) 2024/2025
We would also like to inform you that the Annual General Meeting 2023/2024 is scheduled for November 21st, 2024, to be held in Malmö, Sweden.
To receive information from the company, please subscribe at https://hamletbiopharma.com/subscribe/).
For more information please contact:
Martin Erixon, CEO, Hamlet BioPharma AB, +46733 00 43 77
martin.erixon@hamletpharma.com
Catharina Svanborg, Chairman of the board, Hamlet BioPharma AB, +46 709 42 65 49,
catharina.svanborg@hamletpharma.com